Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
In this webinar Dr Daniel Dever, Stanford University, describes a reproducible CRISPR-Cas9-based protocol for gene editing in hematopoietic stem cells.
Publish Date:
November 28, 2018
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Publish Date: June 26, 2018 -
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017
